PubMed (RefSeq) for id: 209969678

Year	Number of Results
1998	3
1999	3
2000	4
2001	7
2002	6
2003	4
2004	8
2005	7
2006	6
2007	16
2008	15
2009	10
2010	21
2011	20
2012	20
2013	23
2014	16
2015	16
2016	17
2017	15
2018	8
2019	9
2020	15
2021	8
2022	15
2023	8
2024	1

1

Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7.

Baxter JS, Brough R, Krastev DB, Song F, Sridhar S, Gulati A, Alexander J, Roumeliotis TI, Kozik Z, Choudhary JS, Haider S, Pettitt SJ, Tutt ANJ, Lord CJ. Baxter JS, et al. Mol Oncol. 2024 Feb;18(2):369-385. doi: 10.1002/1878-0261.13537. Epub 2023 Oct 22. Mol Oncol. 2024. PMID: 37866880 Free PMC article.

2

N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer.

Su J, Li R, Chen Z, Liu S, Zhao H, Deng S, Zeng L, Xu Z, Zhao S, Zhou Y, Li M, He X, Liu J, Xue C, Bai R, Zhuang L, Zhou Q, Zhang S, Chen R, Huang X, Lin D, Zheng J, Zhang J. Su J, et al. Cancer Res. 2023 Sep 15;83(18):3059-3076. doi: 10.1158/0008-5472.CAN-22-3346. Cancer Res. 2023. PMID: 37326469

3

The adapter protein FADD provides an alternate pathway for entry into the cell cycle by regulating APC/C-Cdh1 E3 ubiquitin ligase activity.

Awadia S, Sitto M, Ram S, Ji W, Liu Y, Damani R, Ray D, Lawrence TS, Galban CJ, Cappell SD, Rehemtulla A. Awadia S, et al. J Biol Chem. 2023 Jun;299(6):104786. doi: 10.1016/j.jbc.2023.104786. Epub 2023 May 4. J Biol Chem. 2023. PMID: 37146968 Free PMC article.

4

Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.

Golkowski M, Lius A, Sapre T, Lau HT, Moreno T, Maly DJ, Ong SE. Golkowski M, et al. Mol Cell. 2023 Mar 2;83(5):803-818.e8. doi: 10.1016/j.molcel.2023.01.015. Epub 2023 Feb 2. Mol Cell. 2023. PMID: 36736316 Free PMC article.

5

Structural investigation of CDCA3-Cdh1 protein-protein interactions using in vitro studies and molecular dynamics simulation.

Barbhuiya TK, Fisher M, Boittier ED, Bolderson E, O'Byrne KJ, Richard DJ, Adams MN, Gandhi NS. Barbhuiya TK, et al. Protein Sci. 2023 Mar;32(3):e4572. doi: 10.1002/pro.4572. Protein Sci. 2023. PMID: 36691744 Free PMC article.

6

The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.

Zhang S, You X, Zheng Y, Shen Y, Xiong X, Sun Y. Zhang S, et al. J Clin Invest. 2023 Feb 15;133(4):e162434. doi: 10.1172/JCI162434. J Clin Invest. 2023. PMID: 36548081 Free PMC article.

7

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

Cao YF, Xie L, Tong BB, Chu MY, Shi WQ, Li X, He JZ, Wang SH, Wu ZY, Deng DX, Zheng YQ, Li ZM, Xu XE, Liao LD, Cheng YW, Li LY, Xu LY, Li EM. Cao YF, et al. Cell Death Differ. 2023 Feb;30(2):527-543. doi: 10.1038/s41418-022-01104-x. Epub 2022 Dec 16. Cell Death Differ. 2023. PMID: 36526897 Free PMC article.

8

APC/C CDH1 ubiquitinates STAT3 in mitosis.

Bhattacharjee D, Kaveti S, Jain N. Bhattacharjee D, et al. Int J Biochem Cell Biol. 2023 Jan;154:106333. doi: 10.1016/j.biocel.2022.106333. Epub 2022 Nov 17. Int J Biochem Cell Biol. 2023. PMID: 36400381

9

Deubiquitinase USP35 stabilizes BRPF1 to activate mevalonate (MVA) metabolism during prostate tumorigenesis.

Lin G, Huang T, Zhang X, Wang G. Lin G, et al. Cell Death Discov. 2022 Nov 10;8(1):453. doi: 10.1038/s41420-022-01231-x. Cell Death Discov. 2022. PMID: 36357379 Free PMC article.

10

USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1.

Zhang Z, Liu W, Bao X, Sun T, Wang J, Li M, Liu C. Zhang Z, et al. Am J Cancer Res. 2022 Aug 15;12(8):3644-3661. eCollection 2022. Am J Cancer Res. 2022. PMID: 36119839 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

270 results

Results by year